Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
J&J says Kenvue tender offer was oversubscribed, expects 23.8% of tendered shares will be exchanged
09:46am, Monday, 21'st Aug 2023
Johnson & Johnson JNJ said Monday that 802.7 million shares of its common stock were validly tendered and not validly withdrawn in a Kenvue Inc. KVUE tender offer that expired at midnight Friday. The
J&J Exchange Offer for Kenvue Is Substantially Oversubscribed
09:38am, Monday, 21'st Aug 2023
Johnson & Johnson investors who elected to participate in the swap will see just 23.8% of their shares converted into Kenvue stock
The 7 Most Undervalued Dividend Stocks to Buy Now: August 2023
04:52pm, Sunday, 20'th Aug 2023
Generating passive income is easier said than done. A lot of investors look for dividend stocks to enjoy steady and consistent income.
10 Dividend Growth Stocks For August 2023
09:00am, Saturday, 19'th Aug 2023
The article presents the ten highest-quality Dividend Radar stocks for further research and possible investment. To rank stocks, I do a quality assessment and sort stocks by quality scores, breaking t
4 moments from Jim Cramer's August Monthly Meeting of the CNBC Investing Club
03:28pm, Thursday, 17'th Aug 2023
Here's a sneak peek.
Jim Cramer gives his view on what investors should do if they own J&J stock
03:13pm, Thursday, 17'th Aug 2023
Jim Cramer talks about the Johnson & Johnson exchange offer for shares of its split off consumer unit Kenvue. In the CNBC Investing Club's Monthly Meeting, Jim gave his view of what do to about J&J.
Here's Why it is a Good Time to Buy J&J's (JNJ) Stock Now
01:17pm, Thursday, 17'th Aug 2023
J&J's (JNJ) Pharma sales are being driven by key drugs like Darzalex and new products. J&J's Pharma and MedTech units are likely to continue to drive sales growth in 2023.
Pharma stocks are typically shunned by Wall St. when people feel confident about economy: Jim Cramer
07:32pm, Wednesday, 16'th Aug 2023
'Mad Money' host Jim Cramer talks the Pharma industry facing off against the federal government over IRA provisions.
The 3 Most Undervalued Retirement Stocks to Buy Now: August 2023
04:14pm, Wednesday, 16'th Aug 2023
The past few years have made many people realize the importance of building a retirement portfolio. Having dealt with a pandemic, layoffs, and inflation, investors realize the importance of having a s
Nearing Retirement? These Stocks Are as Safe as They Come
11:19am, Wednesday, 16'th Aug 2023
Johnson & Johnson has a fortress-like balance sheet. Coco-Cola generates lots of durable (and growing) cash flow.
A New Stock Is About to Join the S&P 500. Does History Show That Buying It Now Could Pay Off?
05:50am, Wednesday, 16'th Aug 2023
Johnson & Johnson spinoff Kenvue will soon be added to the S&P 500. History has shown that stocks often enjoy a boost after the announcement of their addition to the S&P 500.
Johnson & Johnson (JNJ) Presents at UBS MedTech, Tools and Genomics Summit Conference (Transcript)
08:01pm, Tuesday, 15'th Aug 2023
Johnson & Johnson (NYSE:JNJ ) UBS MedTech, Tools and Genomics Summit Conference Call August 15, 2023 2:00 PM ET Company Participants Celine Martin - Group Chairman Jasmina Brooks – President, Biosen
Johnson & Johnson Stock: Outlook Amid Lawsuits
08:45am, Tuesday, 15'th Aug 2023
Renewed uncertainty in relation to Johnson & Johnson's talc lawsuit settlement led to a brief and temporary selloff in JNJ stock. What was Mr. Market thinking? It looks like a "once and for all" resol
7 Dividend Stocks to Buy as Investor Sentiment Falters
03:38pm, Monday, 14'th Aug 2023
While optimism in the broader market remains robust – particularly for hyped-up sectors like technology – investors may still want to consider the relative safety of dividend stocks to buy. Notabl
What pharma brands will be impacted by Medicare price negotiations
02:59pm, Monday, 14'th Aug 2023
Jared Holz, Mizuho healthcare strategist, joins 'The Exchange' to discuss Medicare drug price negotiations, the M&A impact of government intervention into drug pricing, and more.
